iSpecimen Inc Project Introduction, Team, Financing and News_RootData

Tokenized Assets

Ticker	Exchange	Price	24H	Spread	Liquidity ±2%	24H Volume	OI	Funding	Max Leverage	Fees

Event Calendar

Dec 31, 2023

iSpecimen has launched a SaaS platform and a next-generation gene sequencing (NGS) program

Sep 5, 2025

Biological sample procurement company iSpecimen plans to establish a US$200 million digital asset library to purchase SOL through OTC

Team

Robert Lim

CEO

Yuying Liang

CFO

Katie Field

Board Member

Avtar Dhaliwal

Board Member

Anthony Lau

Independent Director